Pfizer’s $43B Seagen Takeover Gets EU Merger Review
Pfizer Inc.’s $43 billion takeover of Seagen Inc. faces a European Union review after the companies formally notified the bloc’s merger watchdog. The European Commission set Oct. 19 as a deadline to complete its initial probe, according to a filing on its website on Friday. Read the full article: Pfizer’s $43B Seagen Takeover Gets EU …
Pfizer’s $43B Seagen Takeover Gets EU Merger Review Read More »